Literature DB >> 1350382

G protein activation of a hormone-stimulated phosphatase in human tumor cells.

M G Pan1, T Florio, P J Stork.   

Abstract

The growth-inhibiting peptide hormone somatostatin stimulates phosphotyrosine phosphatase activity in the human pancreatic cell line MIA PaCa-2. This hormonal activation was mediated by a pertussis toxin-sensitive guanosine 5'-triphosphate-binding protein (G protein) in the membranes of these cells. Activation of this G protein by somatostatin stimulated the dephosphorylation of exogenous epidermal growth factor receptor prepared from A-431 cells in vitro. This pathway may mediate the antineoplastic action of somatostatin in these cells and in human tumors and could represent a general mechanism of G protein coupling that is utilized by normal cells in the hormonal control of cell growth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350382     DOI: 10.1126/science.256.5060.1215

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  28 in total

1.  Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin.

Authors:  D B Reardon; S L Wood; D L Brautigan; G I Bell; P Dent; T W Sturgill
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

Review 2.  Somatostatin.

Authors:  T Reisine
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

Review 3.  Molecular pharmacology of somatostatin receptor subtypes.

Authors:  Y C Patel
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

Review 4.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

5.  A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.

Authors:  G Kéri; J Erchegyi; A Horváth; I Mezõ; M Idei; T Vántus; A Balogh; Z Vadász; G Bökönyi; J Seprõdi; I Teplán; O Csuka; M Tejeda; D Gaál; Z Szegedi; B Szende; C Roze; H Kalthoff; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

6.  Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors.

Authors:  Fabrizio Griffero; Antonio Daga; Daniela Marubbi; Maria Cristina Capra; Alice Melotti; Alessandra Pattarozzi; Monica Gatti; Adriana Bajetto; Carola Porcile; Federica Barbieri; Roberto E Favoni; Michele Lo Casto; Gianluigi Zona; Renato Spaziante; Tullio Florio; Giorgio Corte
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

7.  Ca(2+)-independent reduction of N-methyl-D-aspartate channel activity by protein tyrosine phosphatase.

Authors:  Y T Wang; X M Yu; M W Salter
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

8.  Epidermal growth factor stimulates substrate-selective protein-tyrosine-phosphatase activity.

Authors:  S M Hernández-Sotomayor; C L Arteaga; C Soler; G Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

9.  Intracellular ATP and GTP are both required to preserve modulation of N-type calcium channel current by norepinephrine.

Authors:  K S Elmslie; M A Werz; J L Overholt; S W Jones
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

10.  Regulation of colonic apical potassium (BK) channels by cAMP and somatostatin.

Authors:  M D Perry; G I Sandle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-30       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.